A new study claims that the antibodies created through the Johnson & Johnson COVID-19 vaccine may not be as strong as those created by the Pfizer and Moderna vaccines.
But experts say the study is no cause to rush to conclusions about the vaccine.
Experimental NIH Malaria Monoclonal Antibody Protective In Malian Children
One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali..
Eurasia Review